The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Regulatory activities for this sponsor.
Loading...
Sponsor content
38 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Bimzelx bimekizumab 320 mg/2 mL solution for injection safety syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Bimzelx bimekizumab 320 mg/2 mL solution for injection auto-injector.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FINTEPLA fenfluramine 2.2 mg/mL Oral Solution Bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ZILBRYSQ zilucoplan (as tetrasodium) 23.0 mg/ 0.574 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ZILBRYSQ zilucoplan (as tetrasodium) 32.4 mg/ 0.810 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ZILBRYSQ zilucoplan (as tetrasodium) 16.6 mg/ 0.416 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Bimzelx bimekizumab 160 mg/1 mL solution for injection safety syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Bimzelx bimekizumab 160 mg/1 mL solution for injection auto-injector.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VIMPAT lacosamide 10 mg/mL oral solution bottle.